Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study

被引:1
作者
Ma, Xiangming [1 ]
Jia, Jianguo [1 ]
Cui, Haozhe [3 ]
Zhou, Jing [2 ]
Tian, Fei [4 ]
Yang, Jingtao [5 ]
Zhang, Yali [1 ]
Dai, Jiaying [2 ]
Cao, Liying [1 ]
机构
[1] Kailuan Gen Hosp, Dept Hepatobiliary Surg, Tangshan 063000, Peoples R China
[2] North China Univ Sci & Technol, Grad Sch, Tangshan, Peoples R China
[3] Nankai Univ, Sch Med, Tianjin, Peoples R China
[4] North China Univ Sci & Technol, Affiliated Hosp, Dept Radiat Oncol, Tangshan, Peoples R China
[5] North China Univ Sci & Technol, Affiliated Hosp, Dept Hematol, Tangshan, Peoples R China
关键词
Metabolic dysfunction-associated fatty liver disease; TG/HDL-C ratio; Cohort study; INSULIN-RESISTANCE; CARDIOVASCULAR EVENTS; VLDL; OVERPRODUCTION; ADIPONECTIN;
D O I
10.1186/s12876-024-03471-w
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background The triglyceride to high density lipoprotein cholesterol ratio (TG/HDL-C) is a confirmed predictive factor for insulin resistance and is suggested to be closely related to metabolic dysfunction-associated fatty liver disease (MAFLD), but previous research is inconclusive. The association between TG/HDL-C and MAFLD incidence was further explored in this large-sample, long-term retrospective cohort study. Methods Individuals who participated in the Kailuan Group health examination from July 2006 to December 2007 (n = 49,518) were included. Data from anthropometric and biochemical indices, epidemiological surveys, and liver ultrasound examinations were collected and analysed statistically, focusing on the association between TG/HDL-C and the incidence of MAFLD. Results During a mean follow-up period of 7.62 +/- 3.99 years, 24,838 participants developed MAFLD. The cumulative MAFLD incidence rates associated with the first to fourth quartiles of TG/HDL-C were 59.16%, 65.04%, 71.27%, and 79.28%, respectively. The multivariate Cox proportional hazards regression model revealed that the hazard ratios (HRs) (95% CIs) for MAFLD in the second, third, and fourth quartiles were 1.20 (1.16-1.25), 1.50 (1.45-1.56), and 2.02 (1.95-2.10) (P for trend < 0.05), respectively, and the HR (95% CI) corresponding to an increase of one standard deviation in TG/HDL-C was 1.10 (1.09-1.11) (P < 0.05). Subsequent subgroup and sensitivity analyses yielded results similar to those of the main analyses. Conclusions TG/HDL-C is independently associated with MAFLD risk, with higher TG/HDL-C indicating greater MAFLD risk.
引用
收藏
页数:11
相关论文
共 29 条
  • [1] Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity
    Arita, Y
    Kihara, S
    Ouchi, N
    Takahashi, M
    Maeda, K
    Miyagawa, J
    Hotta, K
    Shimomura, I
    Nakamura, T
    Miyaoka, K
    Kuriyama, H
    Nishida, M
    Yamashita, S
    Okubo, K
    Matsubara, K
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (01) : 79 - 83
  • [2] Triglycerides to high-density lipoprotein cholesterol ratio for diagnosing nonalcoholic fatty liver disease
    Catanzaro, Roberto
    Selvaggio, Federica
    Sciuto, Morena
    Zanoli, Luca
    Yazdani, Azam
    He, Fang
    Marotta, Francesco
    [J]. MINERVA GASTROENTEROLOGY, 2022, 68 (03): : 261 - 268
  • [3] Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research
    Chen, Zekai
    Qi, Hailun
    Qiu, Shaobin
    Chen, Guanzhi
    Chen, Youren
    [J]. LIPIDS IN HEALTH AND DISEASE, 2019, 18 (01)
  • [4] Adiponectin and lipoprotein metabolism
    Christou, G. A.
    Kiortsis, D. N.
    [J]. OBESITY REVIEWS, 2013, 14 (12) : 939 - 949
  • [5] American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
    Cusi, Kenneth
    Isaacs, Scott
    Barb, Diana
    Basu, Rita
    Caprio, Sonia
    Garvey, W. Timothy
    Kashyap, Sangeeta
    Mechanick, Jeffrey I.
    Mouzaki, Marialena
    Nadolsky, Karl
    Rinella, Mary E.
    Vos, Miriam B.
    Younossi, Zobair
    [J]. ENDOCRINE PRACTICE, 2022, 28 (05) : 528 - 562
  • [6] Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study
    Fan, Nengguang
    Peng, Liang
    Xia, Zhenhua
    Zhang, Lijuan
    Song, Zhiyi
    Wang, Yufan
    Peng, Yongde
    [J]. LIPIDS IN HEALTH AND DISEASE, 2019, 18 (1)
  • [7] Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
    Ferguson, Daniel
    Finck, Brian N.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (08) : 484 - 495
  • [8] Mechanisms of NAFLD development and therapeutic strategies
    Friedman, Scott L.
    Neuschwander-Tetri, Brent A.
    Rinella, Mary
    Sanyal, Arun J.
    [J]. NATURE MEDICINE, 2018, 24 (07) : 908 - 922
  • [9] Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study
    Fukuda, Yukiko
    Hashimoto, Yoshitaka
    Hamaguchi, Masahide
    Fukuda, Takuya
    Nakamura, Naoto
    Ohbora, Akihiro
    Kato, Takahiro
    Kojima, Takao
    Fukui, Michiaki
    [J]. LIVER INTERNATIONAL, 2016, 36 (05) : 713 - 720
  • [10] The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort
    Gasevic, Danijela
    Frohlich, Jiri
    Mancini, G. B. John
    Lear, Scott A.
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2012, 61 (04): : 583 - 589